Literature DB >> 1847481

The N-terminal 513 amino acids of the envelope glycoprotein gB of human cytomegalovirus stimulates both B- and T-cell immune responses in humans.

Y N Liu1, A Klaus, B Kari, M F Stinski, J Eckhardt, R C Gehrz.   

Abstract

Host defense against human cytomegalovirus (HCMV) involves both humoral and cell-mediated immunity. In this report, human immune responses to glycoproteins encoded by the HCMV gB homolog gene have been examined by using glycoproteins purified by immunoaffinity from HCMV virions and recombinant proteins expressed by vaccinia viruses containing either the entire gB open reading frame or a C-terminal deletion mutant, gBm165, coding for the N-terminal 513 amino acids of gB. Neutralizing antibodies, helper T cells, and cytotoxic T cells reactive with epitopes on the N-terminal portion of gB were detected in some seropositive individuals, suggesting that this region of gB may be important in eliciting protective immunity during natural infection for some individuals.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847481      PMCID: PMC239955     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Identification and characterization of three distinct families of glycoprotein complexes in the envelopes of human cytomegalovirus.

Authors:  D R Gretch; B Kari; L Rasmussen; R C Gehrz; M F Stinski
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Characterization of a human cytomegalovirus glycoprotein complex (gcI).

Authors:  D R Gretch; R C Gehrz; M F Stinski
Journal:  J Gen Virol       Date:  1988-06       Impact factor: 3.891

3.  Characterization of monoclonal antibodies reactive to several biochemically distinct human cytomegalovirus glycoprotein complexes.

Authors:  B Kari; N Lussenhop; R Goertz; M Wabuke-Bunoti; R Radeke; R Gehrz
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

4.  General characterization of human cytomegalovirus-specific proliferative CD4+ T cell clones.

Authors:  Y N Liu; J Eckhardt; B Kari; R C Gehrz
Journal:  Int J Cell Cloning       Date:  1988-09

5.  Structure and composition of a family of human cytomegalovirus glycoprotein complexes designated gC-I (gB).

Authors:  B Kari; Y N Liu; R Goertz; N Lussenhop; M F Stinski; R Gehrz
Journal:  J Gen Virol       Date:  1990-11       Impact factor: 3.891

6.  Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes.

Authors:  J W Yewdell; J R Bennink; G L Smith; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

7.  Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus.

Authors:  W J Britt
Journal:  Virology       Date:  1984-06       Impact factor: 3.616

8.  Characterization of two different human cytomegalovirus glycoproteins which are targets for virus neutralizing antibody.

Authors:  L Rasmussen; M Nelson; M Neff; T C Merigan
Journal:  Virology       Date:  1988-04       Impact factor: 3.616

9.  Mapping of the major glycoprotein gene of human cytomegalovirus.

Authors:  M Mach; U Utz; B Fleckenstein
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

10.  Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses.

Authors:  L K Borysiewicz; J K Hickling; S Graham; J Sinclair; M P Cranage; G L Smith; J G Sissons
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  4 in total

1.  Human cytomegalovirus glycoprotein B contains autonomous determinants for vectorial targeting to apical membranes of polarized epithelial cells.

Authors:  S Tugizov; E Maidji; J Xiao; Z Zheng; L Pereira
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

2.  Characterization of a panel of insertion mutants in human cytomegalovirus glycoprotein B.

Authors:  J Singh; T Compton
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Escape of human cytomegalovirus from HLA-DR-restricted CD4(+) T-cell response is mediated by repression of gamma interferon-induced class II transactivator expression.

Authors:  E Le Roy; A Mühlethaler-Mottet; C Davrinche; B Mach; J L Davignon
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

4.  Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.

Authors:  Felix Wussow; Flavia Chiuppesi; Joy Martinez; John Campo; Erica Johnson; Christin Flechsig; Maegan Newell; Elaine Tran; Jose Ortiz; Corinna La Rosa; Andreas Herrmann; Jeff Longmate; Rana Chakraborty; Peter A Barry; Don J Diamond
Journal:  PLoS Pathog       Date:  2014-11-20       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.